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Abstract 
Viruses spread between cells, tissues and organisms by cell-free and cell-cell 
transmissions.  Both mechanisms enhance disease by different viruses, but it is 
difficult to distinguish between them.  Here, we analyzed the transmission mode of 
human adenovirus (HAdV) in monolayers of epithelial cells by wet lab 
experimentation and a computer simulation.  Using live-cell fluorescence 
microscopy and replication-competent HAdV2 expressing green fluorescent 
protein we found that infection spread invariably occurred after cell lysis.  It was 
affected by convection, and blocked by neutralizing antibodies, but independent of 
second round infections.  If cells were overlaid with agarose, convection was 
blocked and round-shaped plaques developed around lytic infected cells.  Infected 
cells that did not lyse did not give rise to plaques highlighting the importance of 
cell-free transmission.  Key parameters for cell-free virus transmission were the 
time from infection to lysis, the dose of free viruses determining infection 
probability, and the diffusion of single HAdV in aqueous medium.  With these 
parameters, we developed an in silico model using multi-scale hybrid dynamics, 
cellular automata and particle strength exchange.  This ‘white box’ model is based 
on experimentally determined parameters, and reproduces viral infection 
spreading as a function of local concentration of free viruses.  These analyses 
imply that the extent of lytic infections can be determined by either direct plaque 
assays, or they can be predicted by calculations of virus diffusion constants and 
modeling.  
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Introduction  
Viral disease develops from complex interactions of viruses with their hosts during 
entry, genome uncoating, translation, replication, and assembly and spread of 
progeny viruses to uninfected cells.  Spread of viruses between cells occurs by 
cell-free or cell-to-cell transmissions (for reviews, see 14, 72, 83).  Cell-free 
transmissions require the dissociation of progeny particles from a producer cell, 
and involve large bursts of released viruses or the progressive release of smaller 
amounts of viruses, independent of a particular acceptor cell.  This leads to 
viremia and enables viral spreading throughout blood fluids.  Cell-cell 
transmissions occur at contact sites of neighboring cells.  Neurotropic viruses, for 
example, can be transmitted between synaptic contacts of adjacent cells, and 
retroviruses establish new cell-cell contacts for transmission, so called virological 
synapses (see 23, 68, 69).  For retroviruses, such as human immunodeficiency 
virus (HIV) or equine infectious anemia virus cell-to-cell transmission reduces the 
neutralization efficacy of anti-viral antibodies and anti-viral drugs (66, 91, 113).  
This illustrates that viral transmission modes modulate the efficacy of immune 
defense, and they impact on anti-viral strategies, such as vaccine design and the 
development of new anti-viral compounds.   
Little is known about lytic cell-free transmission of viruses, although it occurs with 
both non-enveloped and enveloped viruses, and is key for clinical efficacy of 
oncolytic viruses (57, 78, 111).  Theoretical calculations considering the rate of 
viral production, life-span of the producer cell and the neutralizing capacity of 
antibodies have suggested that the lytic life cycle with large burst-sizes promotes 
survival in the face of antibody attack (51).  The lytic cycle can be modulated by 
the replication rate, and thereby avoid extinction of the host cells and dilution of 
the virus (114).  Accordingly, viral strains with variable replication rates coexist 
rather than dominate one another.  This is illustrated by persistent non-enveloped 
lytic viruses in vivo and in cell lines, for example poliovirus (22), coxsackievirus 
(100), foot-and-mouth disease virus (24), reovirus (1) or human adenovirus 
(HAdV, 33, 101).   
HAdVs replicate in experimentally infected people, and are transmitted between 
individuals (59).  They cause infections with epidemic, endemic or sporadic 
 4 
disease and viremia or massive viral excretions (73, 89).  Currently, there are 57 
HAdV types grouped in 8 species, including a recently discovered zoonotic 
TMAdV (18).  More than one third of HAdVs are associated with disease in the 
respiratory, digestive, excretory and ocular systems (44, 55, 71).  Fatal cases of 
HAdV infections were reported from immunosuppressed patients due to T-
lymphocyte deficiencies (52), while infections in immune-competent individuals are 
usually self-limiting. 
HAdVs have a diameter of about 90 nm and a double-stranded DNA genome of 36 
kb, but no envelope (7, 61, 82).  The protruding fibers mediate virus attachment to 
cellular receptors.  These receptors include trans-membrane proteins, such as the 
coxsackievirus adenovirus receptor (CAR), membrane cofactor CD46 or 
desmoglein-2, or glycans (8, 32, 75, 92, 105, 108).  Infections with HAdV2 (short 
Ad2), HAdV3 or HAdV5 (short Ad5) are enhanced by integrin coreceptors, which 
bind to the penton base protein on the viral capsid (2, 60).  CAR and integrins are 
localized on the basolateral and junctional membrane of polarized epithelial cells, 
facing away from the airways of the lungs.  These receptors can be redirected to 
the apical surface by virus stimulated macrophages and cytokine signaling, and 
thereby provide a vital passageway for the viruses into the epithelial cells (63).  
Downstream of receptor binding, Ad2/5 engages drifting motions on CAR and is 
confined by integrins (15).  Drifts and confinements trigger the first steps in the 
uncoating program, the loss of the fibers and exposure of the membrane lytic 
protein VI (15, 39, 112).  This is followed by receptor-mediated endocytosis (70), 
and enables virus escape from endosomes (34).  The cytosolic viruses traffic on 
microtubules using the dynein/dynactin motor complex to reach the nucleus (12, 
29, 35, 54, 99).  They dock to the nuclear pore complex, disassemble by a kinesin 
motor-mediated disruption process, and release the viral genome into the nucleus 
(98, 106).  In the nucleus, they initiate the replication program by transcribing the 
immediate early activator proteins of the E1 region encoding E1A and E1B 
proteins, which are essential to drive the expression of all other viral proteins (10).  
The formation of progeny particles in the nucleus requires the replication of the 
viral DNA, and structural viral proteins from the major late transcript (reviewed in 
9).  
While there is experimental evidence for lytic and non-lytic egress of Ad5 (102), 
the mechanisms of lytic viral release and spread from infected cells are poorly 
 5 
understood.  Proteolytic cleavage of cytokeratin K18 by the viral protease is 
thought to reduce the mechanical stability of the cytoplasm, and facilitate viral 
release (20, 65).  In addition, the release of Ad2/5 is facilitated by the adenovirus-
death protein 11.6 kDa encoded in the early region 3A (E3A) (102).  Although 
encoded in E3, the 11.6 kDa protein is expressed at very low levels in the early 
phase of infection, and at very high levels late in infection from the major late 
promoter (103).   
The early region 3B does not directly affect the replication cycle of the virus.  It 
encodes three proteins, which protect the virus from host anti-viral responses in 
acute infections (58).  These proteins antagonize cell death triggered by cytotoxic 
lymphocytes or cytokines released by activated macrophages.  Two E3B proteins, 
10.4 kDa and the 14.5 kDa, form the receptor internalization and degradation 
complex (RID).  RID triggers endocytosis and lysosomal degradation of the Fas 
receptor and TRAIL receptors 1 and 2 (reviewed in 9).  The third open reading 
frame in the E3B region is the 14.7 kDa protein.  It inhibits tissue necrosis factor 
(TNF) alpha (36), TRAIL (104) and Fas ligand induced apoptosis (19) by binding to 
a caspase downstream of the receptors.  This protein also blocks NFkB signaling, 
which is crucial for anti-viral immunity (reviewed in 9).   
HAdV egress from an infected cell in a multi-cellular environment has not been 
quantitatively described so far.  Here, we developed a multi-scale hybrid dynamics 
model using a cellular automaton and particle strength exchange based on 
experimentally determined parameters.  Computational models have been 
developed to study viral propagation between cells, typically based on ordinary 
differential equations (11, 79, 97).  Cellular automata (CA) have been used to 
study viral infection spread, because of their natural discreteness and the ability to 
resolve spatial localization (6, 50, 115).  They were used to model virus spread in 
cell culture, albeit without quantifying diffusion dynamics and accounting for bulk 
currents (4).  While CA are useful for the discrete modeling of cell behavior, they 
are not very suitable for modeling virus particle diffusion in the extracellular space.  
To relax limitations of discreteness and dimensions, hybrids of established 
modeling approaches were developed (64).  Our hybrid spatio-temporal model for 
the propagation of HAdV infection combines CA with a partial differential equation 
formalized by a particle strength exchange (PSE) method (25) to describe diffusion 
of viruses in the cell-free environment.  We show that passive mass transfer of 
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released HAdV progeny in the cell-free environment is sufficient to explain the 
dynamics of HAdV infection spread in monolayers.  
 
Materials and Methods 
 
Cell culture and viruses 
Human lung carcinoma A549 (HLC-A549) cells were purchased from American 
Type Culture Collection (Rockville, MD, USA).  Early region 1 (E1) transfected 
HER-911 cells (31) were grown as monolayers in Dulbecco’s modified Eagle 
medium (DMEM) supplemented with 10% fetal bovine serum (FBS, GIBCO-BRL) 
on cell culture dishes or 96-well plates (Matrix, Thermo Fisher Scientific, 
Lausanne, Switzerland). 
Ad2-dE3B-GFP was constructed in E. coli strain SW102 by mutagenesis of a 
bacterial artificial chromosome (BAC53) carrying the entire Ad2 genome and the 
phage lambda recombineering genes, which allowed for a 2-step GalK positive 
selection and deoxy-galactose counter-selection as described earlier (46, 48, 81, 
109).  The E3B genes were excised at the end of the E3A poly-adenylation site 
(nucleotide 29780) and before the E3B poly-adenylation site (nucleotide 30841), 
and replaced by GalK using the following primer pair: 5’ 
gaaaccatgttctcttcttttacagtatgattaaatgagaccctgttgacaattaatcatcggca 3’ and 5’ 
gctggacaaagatttgctgactgattttaagtaagtaatttattgtcagcactgtcctgctcctt 3’.  The eGFP 
open-reading frame controlled by a CMV promoter and an SV40 termination site of 
1642 bp was inserted in place of GalK using the following primer pair: 
5’gaaaccatgttctcttcttttacagtatgattaaatgagactagttattaatagtaatcaattacggggtc3’, 
5’gctggacaaagatttgctgactgattttaagtaagtaatttattgttaagatacattgatgagtttggacaaacc3’.  
The final BAC construct was verified by DNA sequencing using primers in the E3A 
and the E4 region, and found to be correct (not shown).  Ad2-E3B-eGFP BAC 
DNA was purified using a Maxi preparation kit (Sigma), linearized by Dpn I 
restriction, phenol-chloroform extracted, ethanol precipitated and transfected into 
293 cells by calcium phosphate precipitation.  Virus particles were grown in HLC-
A549 cells, and purified by double caesium chloride gradient centrifugation.  Ad2-
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E3B-eGFP was found to be homogeneous by SDS-PAGE and transmission EM 
negative stain analyses (not shown).   
For time-resolved infection studies, purified Ad2-dE3B-GFP was added to A549 
cells at 5·10-7 mg/ml protein, about 3 particles per cell.  From the protein 
concentration measured in the purified virus preparation, we determined a 
theoretical number of adenovirus particles (TNAP) according to equation (1) 
 
!
!
The mass of one virus was assumed to be 2.5·10-19 kg, about 150 MDa (107).   
Transgenic Ad2-dE1-GFP was generated by ET recombination mediated insertion 
of a CMV promoter GFP expression cassette to the E1 region of Ad2 (nucleotides 
461-3510).  BAC-DNA was verified for correct insertion of the GFP gene, purified 
and transfected into HER-911 cells for virus growth as described (81).  Ad2, Ad2-
dE3B-GFP and Ad2-dE1-GFP were grown, isolated and in case of Ad2-Atto488 
dye (ATTO-TEC, Germany) as described (15, 31, 38, 74).  Protein concentrations 
of purified viruses were measured using the PIERCE Micro BCA protein assay 
reagent kit (Thermo Fisher Scientific, Lausanne, Switzerland). 
 
Automated cell segmentation and infection probability calculations 
Automated cell segmentation was performed computationally using CellProfiler 2.0 
software (16).  Analysis involved custom-made CellProfiler 2.0 pipeline involving 
thresholding of multiple signal source images.  Thresholding efficiency was 
calibrated visually for each dataset.  Results from automated cell segmentations 
were used to count GFP positive cells 72 hpi.  These values were used to 
calculate the fraction of infected cells depending on input virus concentration.  
These data were used to calculate the probability of infection.   
From the protein mass of an individual HAdV particle (107) we defined TNAP 
using equation (1).  From the fraction of GFP-positive cells calculated, we 
determined the infection probability depending on the amount of input virus and 
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normalized the probability over the typical length of an experiment, which was 72 
h.  We assumed that the majority of the particles attached onto the cell monolayer 
during this period.  This allows us to calculate the impact of TNAP per arbitrary 
area unit on the probability of infection. 
 
Complementary co-cultures of HER-911 and HLC-A549 cells 
HER-911 and HLC-A549 cells were grown to 95% confluence in separate wells of 
a 96-well plate.  HER-911 cells were inoculated with Ad2-dE1-GFP (MOI 104, 
0.053 !g/!l) in DMEM containing 2% BSA at 37°C for 1 h, washed 3 times with 
PBS, stained with CellMask deep red dye (Invitrogen) and detached with Accutase 
(Sigma-Aldrich) at 37°C for 7 min.  Singular HER-911 cells were re-suspended in 
DMEM containing 10% FBS, diluted 1:800 with DMEM-FBS and added to a 
monolayer of HLC-A549 cells.  Infection was imaged 24 hpi as described below.  
The co-occurrence of CellMask and GFP dyes was quantified by cell segmentation 
with CellProfiler 2.0.   
 
HAdV neutralization  
Ad5 was incubated with an Ad2/5 neutralizing antiserum (kindly obtained from Dr. 
Anja Ehrhardt, 43) in 96 well dishes containing 50 !l of DMEM and 1% BSA.  HLC-
A549 cells were added to the wells, incubated at 37°C for 7 days, fixed and 
stained with the cell-dye crystal violet dye (0.25 mg/ml crystal violet in H2O 
containing 5% EtOH.  
 
Semi-solid medium  
Semi-solid medium was prepared using cell culture grade ultra-low melting 
agarose, type VII (SIGMA, Fluka, Buchs, Switzerland).  Agarose was dissolved in 
PBS at 3 mass percent.  This concentrated gel was heated up to 90° C in a 
microwave oven, cooled down, controlled for water loss and precise agarose 
concentration using gravimetry, volume adjusted by addition of H2O, diluted with 
warm cell growth medium, and overlaid on top of the cell monolayers or used for 
diffusion measurements of purified fluorophore tagged HAdV particles.  
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Time-lapse multi-site multi-channel microscopy 
Time-lapse multi-site multi-channel microscopy images were recorded with an 
automated ImageXpressMICRO fluorescence microscope (Molecular Devices, 
Munich) using 10x Nikon S Fluor objective with 0.5 NA, and equipped with a 
humidified chamber at 37° C and multiple wavelength excitation/emission filters 
(Semrock).  All live imaging experiments were performed in 96-well black plates 
(Matrix, Thermo Fisher Scientific, Lausanne, Switzerland).  For image acquisitions 
cultured cells were maintained in 20 mM Hepes buffered bicarbonate-free Roswell 
Park Memorial Institute 1640 medium (RPMI, GIBCO-BRL) supplemented with 
10% fetal bovine serum (FBS, GIBCO-BRL) and penicillin-streptomycin (GIBCO).  
Image acquisition at multiple sites was enabled with a motorized stage allowing 
precise high speed selection of regions of interest within a well.  Using MATLAB 
(Mathworks, Natick, Massachusetts, USA) based post-processing, images were 
stitched into pictures of high resolution covering roughly 85% of a 96 well in case 
of experiments involving plaque (PQ) analyses.  This allowed analyses of virus 
infection spreading over large areas with high resolution. 
 
Imaging of HAdV particles and fluorescent beads  
The movements of adenovirus particles and fluorescent beads was imaged using 
custom made total internal reflection fluorescence (TIRF) microscopy based on an 
Olympus IX81 inverted microscope equipped with a Cascade 128+ camera 
(Photometrics, Roper Scientific, USA), 100x 1.45 NA oil immersion PlanApo 
(Olympus) objective and a custom made thermostatic chamber (15).  Yellow-green 
Fluoresbrite fluorescent beads size range kit used was purchased from 
Polysciences (USA).  Microscopy was performed at 37° C.  The TIRF angle was 
manually adjusted in each case in order to obtain the optimal signal-to-noise ratio.  
The image acquisition was controlled by Metamorph software (Molecular Devices, 
Visitron Systems, Germany).  For the measurements we used type I ultrapure 
water (18.2 M "/cm) and live imaging medium (Imaging medium).  Imaging 
medium had the following composition: Hank's Buffered Salt Solution (HBSS), 
0.2% Bovine serum albumin (BSA, SIGMA), 1 mg/ml ascorbic acid, optional 10% 
FBS (or without addition of 10% FBS in the case of low serum imaging medium).  
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Measurements were conducted in media containing different concentrations of 
agarose.  Movies with a high time resolution (0.001 s/frame) were acquired and 
used to track individual HAdV particles.  Particle tracking was performed with the 
“particle tracker 3D” plugin in ImageJ (86).  The resulting trajectories were used to 
compute HAdV diffusion constants from the moment scaling spectrum as 
described (30, 37).  
 
Measurement of the HAdV diffusion constants 
The diffusive properties of HAdV particles were determined using high speed TIRF 
microscopy of fluorescently labeled viruses at 1000 Hz acquisition frequency, and 
single-particle tracking in 2-dimensional mode using the “particle tracker 3D” 
ImageJ plug-in (86).  Viral trajectories were used to compute diffusion constants 
from the moment scaling spectrum slope.  The procedure was calibrated using 
various sized fluorescent beads and compared to values predicted by the Einstein-
Stokes equation (2). 
The diffusion constant (D) of a given particle can be calculated theoretically or 
measured experimentally.  Theoretical values of diffusion constants for ideal 
spherical particles can be predicted using the Einstein-Stokes equation  !
 
where D is the diffusion constant, kB Boltzman's constant, T the temperature, ! the 
viscosity of the environment, and r the hydrodynamic radius of the particle. 
 
Determination of the mode of diffusive motions 
To confirm the validity of the theoretically calculated D values from equation (2), 
we characterized the motion mode of the fluorescent beads by estimating the 
Reynolds number (Re).  Re is a measure of the ratio of inertial forces and viscous 
forces acting on the particle.  Equation (2) assumes laminar Stokes flow and is 
only valid for Re much smaller than 1.  In our system we estimated Re for 
Brownian motion of various-sized beads ranging from 38 to 1000 nm (Table 1).  All 
 11 
values of Re were smaller than 0.1, suggesting laminar motion (28), and justifying 
the use of equation (2) for HAdVs.  Equation (2) is also valid for most of the 
currently known globular virus particles.   
 
Computation of the Reynolds number for fluorescent particles 
To confirm the validity of theoretically calculated diffusion constants using equation 
(2), we estimated the Reynolds numbers (Re) for Brownian motion of beads 
ranging from 38 to 1000 nm in diameter.  Equation (2) is only valid if the flow of 
medium around the diffusing virus particle is laminar (28), which is the case for Re 
much lower than 1.  
Re can be computed using equation (3): 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!"#$!
Where " is the density of the fluid, ! the dynamic viscosity of the fluid, V fluid 
velocity, L diameter of the spherical particle.  L for the fluorescent beads were 
purchased from Polysciences (USA).  ! for distilled water at 37°C was computed 
from equation (4): 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!"%$!
where A = 2.41·10-5 Pa·s, B = 247.8 K, and C the fluid temperature in degree 
Kelvin.  # for distilled water at 37°C is 991.27 kg/m3. 
Fluid velocity estimations around the Brownian particle (V) can be obtained using 
several approaches.  For example, it could be measured experimentally, although 
this is limited by the temporal resolution.  From our experimental measurements, 
we computed two types of V, instantaneous speed (Vinst) and mean speed (<V>). 
The trajectories from the 1000 Hz TIRF microscopy experiments were used to 
estimate Vinst, while <V> was computed from experimental D values according to 
equation (5): 
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where t is the time length of the trajectory. 
 
To control for potential underestimations of V values from experimental data we 
computed theoretical instantaneous root mean square velocity values (VRMS) from 
equation (6) according to (56) 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!"'$!
We then computed Re based on maxima of Vinst , <V> and VRMS.  All values of Re 
obtained were smaller than 0.1 (see Table 1), which allowed good theoretical 
predictions of diffusion constants for spherical particles using equation (2).  
Furthermore, the size range over which we calibrated the method covered most 
currently known viruses, which allows equation (2) to predict diffusion constants 
for many other globular virus particles. 
 
Description of the computational model 
The computational model was developed using MATLAB 2010a (The MathWorks, 
Natick, MA, USA).  The model consists of a CA and a PSE module.  The CA is a 
discrete module composed of a grid of cells, each of which in a defined state and 
conforming to rules that are updated according to the present state of the cells.  
PSE is a deterministic particle method to simulate diffusion. 
The implemented CA uses a hexagonal grid to represent biological cells.  The 
state of the cell describes their infection status and viability.  The time step for the 
CA is 1 h, sufficient to resolve key events, such as cell infection and lysis.  At each 
time step, the status of the cell is checked and updated if required.  A lysis clock is 
also updated if the cell state is currently in productive infection mode.  The 
hexagonal CA grid consisted of 200 x 231 cells, 46,200 cells in total.  The size of 
each cell was 24 µm and the total layer of cells 4812 x 4808 µm2. 
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The state of each cell can be uninfected, dead, infected, or non-lysable.  All cells 
are uninfected at the beginning of the simulation, except for one initially infected 
cell.  An uninfected cell can die or be infected or non-lysable.  The proportion of 
dead cells over the course of the biological experiment was calculated.  Uninfected 
cells were chosen randomly to die during the simulation in order to match the ratio 
obtained from the biological experiments.  An uninfected cell may be infected 
based on an experimentally determined probability depending on the local 
concentration of virus.  Between different CA time steps, the maximum TNAP 
concentration was recorded for each cell.  This concentration was compared with 
the probability of infection at the appropriate virus concentration.  A random value 
of 0 or 1 was used to determine if the cell becomes infected by comparison to the 
experimentally obtained probability of infection.  Probabilities of infection between 
experimental concentrations were linearly interpolated, based on the experimental 
observation that not all the infected cells went on to lyse and form PQ.  As soon as 
a cell was infected, this cell was randomly assigned to either proceed to a lytic or a 
non-lytic infection, based on experimentally determined probabilities of infected 
cell lysis.  As soon as a cell was infected, a lysis clock was initiated which then 
determined the time to lysis from a uniform distribution taken after the first infected 
cells were observed to lyse between 1 and 5 days pi (dpi).  The level of GFP 
intensity in lytic or non-lytic infected cells was taken as an indicator for the 
progress of infection.  The GFP intensity signal increased over time as determined 
by linear extrapolation between calculated virus concentrations.  The GFP 
intensity values can be linearly interpolated until selected maximum virus 
concentrations measured in the biological experiments for experimental purposes.  
The PSE diffuses the virus particles released from an infected cell.  The time step 
of the PSE is set to satisfy the forward Euler stability criteria, dt < h2/2D, where h is 
the space between particles, and D the diffusion constant.   The PSE module 
stopped running when the local concentration of virus was below the infection 
threshold.  As a result of multi-scale nature of the CA and PSE components of the 
hybrid model in temporal dimension, the PSE module runs between time steps of 
the CA.  As mentioned above, the maximal concentration of virus the cell is 
exposed to between individual CA steps is tracked during the course of the PSE 
module execution.  The PSE was implemented as described in (25).  Particles 
were placed on a regular grid and the number of particles used was chosen such 
that approximately nine particles gave support to one CA cell.  A cloud-in-cloud 
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assignment scheme was used to add virus to the PSE module after cell lysis, and 
to determine the local concentration of virus at each cell.  
 
Radial distribution function for plaques 
A method to determine the radial distribution function (RDF) of intensity was 
developed to characterize the PQs in biological and in silico experiments.  The 
input for the method was an image (intensity matrix), as well as the user defined 
center of the PQ.  The perimeter of a PQ was scanned by single degree 
resolution, and GFP intensities projecting around the center were averaged in 
concentric rings with a width of 1 pixel (0.645 !m) with 0 pixels spacing.  The 
average intensity from each ring yielded the RDF values.  The center of biological 
PQs was determined by user input, while the center of in silico PQs was taken as 
the initially infected cell. 
 
Experimental and simulated time resolved plaque formation 
Individual PQs from Ad2-dE3B-GFP infected HLC-A549 cells were imaged by live 
cell fluorescence microscopy in hourly intervals as described above, and radii of 
PQs fitted using ImageJ software.  The simulation of PQ formation was performed 
using the parameters described above.  
!
 
 
Results 
 
Ad2 infection visualized in epithelial cell monolayer 
We used ET mutagenesis (81) to engineer a replicating, E3B-deleted Ad2, which 
expresses the GFP reporter in the E3 region from the major cytomegalovirus 
promoter (short Ad2-dE3B-GFP).  This virus was fully replication competent, and 
developed plaques similar in appearance and size in human airway epithelial lung 
carcinoma A549 cells (HLC-A549) as Ad2 (Fig. S1).  Live cell, multi-site time-lapse 
microscopy showed that inoculation of Ad2-dE3B-GFP led to sporadic occurrence 
of GFP-expressing cells in the monolayer, indicating infection.  About 2-3 dpi, 
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larger zones of GFP-positive cells developed around initially GFP-expressing cells.  
We termed these foci plaques (PQ), although in a strict sense they are ‘spreading 
phenotypes’, an example of which is shown in Fig. 1A and B.  Our PQs resemble 
classical viral plaques, which were introduced more than 60 years ago enabling 
the first systematic and quantitative measurements of viral infections (27).  To 
visualize cell lysis we used propidium iodide (PI), a positively charged cell-
impermeable phenanthridine dye, which intercalates with double-stranded DNA 
and RNA and upon binding emits 20-30 fold enhanced orange-red fluorescence at 
617 nanometers compared to the free dye (96).  The PI signal can only be 
observed if the plasma membrane is broken.  The transition of a GFP-positive cell 
to a PI-positive cell occurred faster than the 1 h resolution used in these 
experiments, that is, it appeared in the frame following the initial GFP signal.  For 
the 10 analyzed PQs the transition from an initially infected cell to a PQ usually 
occurred 4 to 14 h after cell lysis (Movie S1).   
We calculated the probability of a PI signal to occur at the time point of the GFP-PI 
transition event, and the geometrical probability of this event to occur inside a 
circular area large enough to contain both the source of the GFP signal and the PI 
signal.  The probability of a double positive GFP and PI-stained cell was less than 
1 in a thousand (P = 0.00045±0.00025, N=10).  We conclude that Ad2-dE3B-GFP 
inoculation leads to a sequential order of events suitable for live cell image 
analyses, initial infection monitored by intense GFP expression, cell lysis by PI 
staining, and secondary infections of neighboring cells, which gives rise to a PQ.  
 
HAdV infection spread involves cell-free virus particles  
To test if PQs depend on the release of free progeny viruses into the medium, we 
tested if convection influenced the shape of the PQs.  Convection is a 
macroscopic description of heat and mass transfer in fluids, and consists of 
advection and diffusion (49).  Advection results from bulk fluid motions caused, for 
example, by local temperature differences.  Advection is cancelled in gels by the 
frictional forces between the liquid and the polymer network (17).  PQs with comet-
like shapes were observed in liquid medium, and circular shapes in semi-solid 
medium (Fig. 2A, B, and Movie S2).  In both cases, the GFP signal was more 
intense in the center of the PQ than the periphery.  The strong influence of 
advection on the development of PQs was underscored by the observation that 
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the comet-shapes were uniformly directed uphill in tilted plates, while they were 
randomly positioned in horizontal plates in liquid medium (Fig. S2).  In gelled 
medium, the PQs were largely symmetrical presumably due to dissipation of 
advection currents caused by friction.   
To test if infection spreading involved extracellular viruses, we used an anti-Ad5 
neutralizing serum (43).  At 1:10 but not at 1:500 dilutions, it blocked single round 
Ad2-dE3B-GFP infection of HLC-A549 cells by about 10-fold (Fig. S3A).  At 1:30 
dilution, it neutralized Ad5 infection of HLC-A549 cells by end point titration assays 
at 104 or less viruses per cell (Fig. S3D).  Higher amounts of antiserum were 
effective also against 105 Ad5 per cell, confirming the high neutralization potency.   
We next inoculated HLC-A549 monolayers in 96 wells with Ad2-dE3B-GFP (5x10-7 
!g/!l, 3 particles per cell), removed the inoculum 24 hpi, covered the cells with 
medium containing neutralizing antiserum and observed the infection by live cell 
GFP imaging.  At the 1:10 dilution of the serum, we observed one PQ per well, 
and 3.5 PQs at 1:500 dilution (Fig. 2C, and Movie S3).  Untreated cells or cells 
treated with heat-inactivated antiserum had an average of about 5 PQs per well, 
and these PQs were larger than the PQs from cells treated with neutralizing 
antibody.  The data show that most PQs were blocked by the neutralizing 
antiserum indicating that extracellular Ad2 drive PQ formation.  A small fraction of 
PQs was resistant to the antibody.  Since PQs only formed from lytic infected cells, 
this suggests that a small amount of extracellular viruses were not recognized by 
the antiserum.  PQ formation, however, depended on passive transfer of infectious 
viruses in the medium, influenced by bulk liquid motions.  These motions comprise 
advection and diffusive mass transfer.  In subsequent experiments, we restrict 
HAdV mass transfer to diffusion with semi-solid medium. 
 
Lysis of a single cell leads to the formation of a plaque  
If HAdV spreads to neighboring cells by passive mass transfer, a single infected 
cell should produce a PQ.  We tested this hypothesis in a co-culture system of 
infected human embryonic retinoblast 911 cells (HER-911), which replicate E1-
deleted Ad2 expressing eGFP (Ad2-dE1-GFP).  Low amounts of infected HER-
911 were seeded onto uninfected HLC-A549 acceptor cells, which can be infected 
but do not replicate Ad2-dE1-GFP, and thereby allow for a single round of infection 
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(Fig. S4).  Live cell, multi-site time-lapse microscopy revealed GFP-positive HER-
911 donor cells 54.5 hpi, followed by lysis of one of the donor cells, and the 
formation of a PQ in HLC-A549 cells at 104.5 hpi (Fig. 3).  These PQs were similar 
in size as those observed with replicating Ad2-dE3B-GFP in HLC-A549 cells, and 
they depended on donor cell lysis and advection (Fig. S5).  We noticed a 
significant amount of dead cells at late imaging time points of both infected or 
uninfected cells (see Fig. 1 and Fig. 3).  This was most likely due to imaging-
induced photo-toxicity. The lysis clock was modeled by a uniform distribution 
probability.  An exponential distribution probability gave similar results (not shown).   
Importantly, in the wet lab experiment, imaging did not affect the size of PQs up to 
3 days pi, as concluded from PQ analyses without intermittent imaging, in 
agreement with our simulations using different lysis clock probabilities (data not 
shown).  Together, the data indicate that viruses spread from a single lysed cell in 
the absence of lytic viral replication in the acceptor cells.   
 
The foundations of a model for lytic spread of HAdV 
To quantitatively characterize the spreading of HAdV infection by a cell-free 
mechanism we developed a novel computational model (for overall workflow of the 
model and the cell state flowchart, see Fig. 4).  The model hybridizes a cellular 
automaton (CA) with particle strength exchange (PSE).  PSE is a mesh-free 
method to simulate diffusion, and is used here to simulate the diffusion of viral 
particles after cell lysis.   
The CA represents the geometry of a monolayer composed of a grid of hexagonal 
digital cells representing the biological cells.  The CA also tracks the states of all 
cells, that is, uninfected, infected, infected and non-lysable, or lysed.  Uninfected 
cells can become infected with a certain probability depending on the viral particle 
concentration at the location of the cell.  In addition, not all cells that are infected 
also lyse and release infectious viruses.  In our model, the productively infected 
cells were assigned an internal clock, which determines when they lyse.  The lysis 
clock starts to tick upon infection, and the expected lysis time is sampled from a 
uniform distribution between 1 and 5 dpi, as determined from our previous 
observations (Fig. 1, Movie S1), in agreement with data from the literature (102).  
When the clock indicates that a cell should lyse, the emerging viral particles are 
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locally added to the PSE simulation using a ‘cloud-in-cell’ assignment scheme 
(47).  The PSE then diffuses the viral particles between time steps of the CA.   
To enhance the relevance of the model, we included the following experimentally 
determined parameters:  i) the average size of a cell, ii) the time lag for an infected 
cell to lyse, iii) the probability for a GFP-positive cell to lyse iv) the diffusion 
constant of HAdV in the extracellular medium, v) the probability of infection as a 
function of local virus concentration vi) the GFP intensity increase rate after 
infection and vii) the probability of cell death for uninfected cells (Fig. 5).  The only 
parameter obtained from the literature was the amount of viral particles released 
from a lysed cell.  It was estimated that one HAdV-infected cell releases 100,000 
to 200,000 viral particles (40, 77).  For the sake of simplicity we used 100,000 in 
our model, unless specified differently.  
i) Average size of a cell.  Our CA model uses a uniform hexagonal cell grid.  The 
cell size was calculated from the average number of Hoechst-stained nuclei on a 
given area from near confluent cells (see Fig. 1B).  Assuming that the approximate 
cell shape is a hexagon, we computed the inner radius (r) of the hexagon from the 
average cell area (A) using the formula: A = 2?3·r2.  The calculated average 
radius of a cell was 12±1 !m, which is in excellent agreement with direct cell 
measurements of cell size (data not shown).    
ii) Time for an infected cell to lyse.  Since cell lysis triggers secondary infection 
rounds, it is important to accurately estimate this parameter of the model. 
According to earlier reports, HAdV-infected cells are expected to lyse 1 to 5 dpi 
(102).  Using live cell imaging of PI, we observed that infected cells started to lyse 
1 to 2 dpi with a uniform probability distribution up to 120 hpi (Fig. 1, Movie S1). 
iii) The probability for an infected cell to lyse.  We observed that for unknown 
reasons not all GFP-positive infected cells lyse and produce a PQ within 5 dpi.  
The ratio between the numbers of PQs developed within 5 days and the number of 
GFP-positive cells before development of PQs (24 hpi) was 7.4±1.2%.   
Based on these findings, we defined that an infected cell can lyse with a 
probability of 0.074 during the 5 days time window.  The probability that an 
infected cell enters a “non-lysable” state was hence 0.926.  
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iv) Diffusion constant of HAdV in the extracellular medium.  The diffusion 
constant (D) of a given particle can be calculated theoretically or measured 
experimentally according to equation (2).  HAdV particles have a complex shape.  
The icosahedral capsid is approximately 90 nm in diameter, and contains 12 
fibers, which project away from the capsid by about 37 nm (61).  If Ad2 were an 
ideal sphere, D would be between 4.06 !m2/s and 7.31 !m2/s for particles with and 
without fibers, respectively.  We experimentally determined D for Ad2 by total 
internal reflection fluorescent (TIRF) microscopy of Ad2-atto488 and single-particle 
tracking analyses using spherical fluorescent beads as internal standards.  
Comparison of the experimental D values for these beads in cell growth medium, 
water or agarose with theoretical values from equation (2) indicated good overall 
correlations, suggesting that our experimental procedures were valid (Fig. S6A, B).  
The experimentally determined DAd2-atto488 of 6.47±19.45 !m2/s in medium was well 
within the range of the theoretically predicted values from equation (2).  Equation 
(2) was valid, since our experimental setup involved mostly laminar Stokes flow, 
as indicated by the computed Reynolds numbers, which were far below 1 for 
beads from 38 to 1000 nm (Table 1, and materials and methods).  As expected, 
DAd2-atto488 was dependent on the concentration of agarose in the semi-solid 
medium (Fig. S6C).  At agarose concentrations above 3%, DAd2-atto488 dropped 
below the values in pure solvent or agarose less than 3%, consistent with the 
diffusive behavior of particles in gels with mesh sizes larger than the particles.  
v) Probability of infection as a function of local virus concentration.  In order 
to fix the infection probability parameter in our model, we measured the 
relationship between the concentration of input Ad2-dE3B-GFP and the probability 
of infection of HLC-A549 (Movie S4).  The proportion of infected cells determined 
by automated computational cell segmentation using CellProfiler (16) increased 
with increasing amounts of virus 72 hpi (Fig. 6A).  Similar results were obtained 
with Ad2-dE1-GFP (Fig. S7A).  Based on these values, we determined how the 
infection probability depends on input virus.  To obtain the probability of infection 
for every CA time step at 1 h sampling frequencies we used the empirically 
determined distributions of probabilities at the local virus concentration over 72 h.  
This approach allowed accounting for the threshold TNAP needed for the 
successful infection of an individual cell.  We thereby took into account potentially 
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non-infectious virus particles and all particles that fail to successfully deliver their 
genome to the nucleus.  The entire infection process was lumped into a single 
probability, which depends on the amount of input virus.  
vi) GFP intensity rate increase after infection.  There was a difference in GFP 
intensity between the center of a PQ and its periphery (see Movie S1 and Fig. S2).  
A similar difference in intensity could be observed when cells were infected with 
different amounts of virus (see Movie S4).  To quantify this intensity difference cell 
monolayers were infected with different concentrations of Ad2-dE3B-GFP, and the 
mean GFP intensity (averaged per well) measured for each virus concentration as 
a function of time (Fig. 6B).  We found that the signal-intensity difference 
correlates with the amount of Ad2-dE3B-GFP used for infection.  The obtained 
values were used to simulate GFP signals in the model.  Similar measurements 
were also carried out and simulated for Ad2-dE1-GFP (Fig. S7B).  In summary, the 
correlation of input virus and intensity of infection allows setting the corresponding 
kinetic parameters in the model.   
vii) Probability of cell death for uninfected cells.  Since dead PI-positive cells 
cannot be infected, we determined the amounts of dead cells as a function of time.  
Particularly towards later time points of infection imaging, we observed a 
significant number of GFP-negative cells turning PI-positive (Fig. 1, Fig. 3, Movie 
S1).  This was independent of infection, as indicated by comparison of the number 
of PI-positive cells in infected and non-infected wells (Fig. 6C).  The observed 
cytotoxicity is most likely caused by limiting cell culture and fluorescence imaging 
conditions.  Based on the appearance of PI-positive cells over time, we computed 
the probability for an uninfected cell to lyse, and incorporated this into our model.  
 
In silico and biological plaques have similar features 
We next ran the hybrid CA-PSE model for Ad2-dE3B-GFP infection with the 
parameters described above and analyzed its output for PQs.  We compared 15 in 
silico PQs with 15 biological PQs.  The patterns predicted by the model resemble 
those of the biological PQs, including features, such as non-infected cells inside 
the zone of PQs and out-lying infected cells (Fig. 7 and Movie S5).   
Using CellProfiler and custom-made software, we measured a number of 
phenotypic parameters of biological and in silico PQs, such as the mean radius, 
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the mean number of infected and non-infected cells, and the mean speed of the 
spreading front, which was computed from the average change of radius over 
time.  The average values of these parameters taken from 15 biological and in 
silico PQs are listed in Table 2.  The radii and the speeds of the spreading front of 
biological and in silico PQs were qualitatively similar, while there were small 
differences in the number of total cells and the number of infected cells within 
PQs.  Since both of these phenotypic features depend on the cell shape, we 
believe that the observed difference is due to the model assuming a uniform 
hexagonal grid with all cells having the same shape and size.  The model does not 
account for biological cell-to-cell variability, which can be due to cell division or 
migration.  We conclude that the model has a good overall ability to predict non-
geometric phenotypic features of PQs, and their emergence and propagation.  
 
Radial distribution function for quantitative model validation 
We next validated quantitative fluorescence intensity distributions of individual 
cells within zones of PQ predicted by the model.  To measure changes of the 
signal intensity from the center of a PQ to the periphery, we used a radial 
distribution function (RDF).  This renders the read-out invariant to sample rotation, 
a suitable feature of radially symmetric PQs.  The RDF quantifies the average 
fluorescence intensity as a function of distance from the center of a PQ, obtained 
by averaging the fluorescence intensity along concentric circles (45).  We first 
measured the RDF of a PQ from single-round infections with Ad2-dE1-GFP.  As 
indicated in Fig. 8A, the RDF captures the visually observed intensity decreased 
with distance from the PQ center.  In addition, the distance-dependent decrease of 
GFP fluorescence intensity, observed in both experimental and simulated RDFs 
quantitatively reflected the signal intensity observed in individual cells of biological 
PQs.  The RDF intensity profile is hence a useful tool to compare in silico PQs and 
biological PQs, in particular if RDFs from multiple PQs are averaged to iron out the 
inherent noise in both in silico and biological PQs.  
 
The virus concentration gradient determines the size of plaques 
Next, we compared the RDFs from experimental PQs and simulated PQs using 
replicating Ad2-dE3B-GFP.  From averaged 15 experimental and 15 independent 
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simulated PQs we found that the intensity decrease of infection was similar in both 
cases, and was strongly dependent on the distance from the PQ center (Fig. 8B, 
C).  We conclude that the distance-dependent intensity decrease of infection is a 
general feature in PQs of both replicating and non-replicating HAdVs.  Our model 
showed that this distance-dependent intensity decrease was caused by a 
concentration gradient of free virus particles formed as a result of virus release 
from an infected cell and free diffusion of virus in the medium.  We suggest that 
this mechanism is responsible for the distance-dependent intensity decrease in the 
biological system. 
 
High local virus concentrations lead to hyper-infection  
The averaged biological and in silico RDFs had a good overall fit of the GFP 
intensities.  For example, the fluorescence intensity dropped to half of the center 
value at about 4 cell diameters (150 !m) from the PQ center in both cases.  We 
hypothesized that the significant difference between the GFP intensity in the 
center and the periphery could be due to a local hyper-infection of cells (MOI much 
larger than 1) with Ad2-dE3B-GFP or Ad2-dE1A-GFP in close proximity to the 
lysed donor cell in the center.  We simulated conditions to suppress the impact of 
hyper-infection on the simulated GFP intensity.  For this, we fixed the maximum 
GFP intensity that could be reached by a simulated cell to experimentally 
measured average GFP intensity obtained with virus concentration of 0.05 !g/!l 
(MOI 104). Here virus concentrations higher than 0.05 !g/!l have the same impact 
on the level of GFP intensity as the concentration of 0.05 !g/!l. (see Fig. 6A).  
Under these conditions, the GFP intensity peak around the PQ center disappeared 
from the simulated RDF (Fig. 8D), in contrast to the non-restricted simulation (Fig. 
8C).  We concluded that the high level of infection in the closest proximity of the 
lysed cell was the result of a high local concentration of released virus particles, 
leading to local hyper-infection.  
 
An estimation of the number of released virus particles 
The number of released virus particles from infected cells may vary from cell to 
cell.  Population values for virus particles produced per cell center around 100,000 
(40, 77).  We computed different RDFs for different numbers of released particles, 
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and averaged them from 15 in silico simulations (Fig. 8E).  As expected, the RDF 
intensity increased with increasing number of released viruses from the lytic 
infected cell in the PQ center.  This led to a proportional increase in the radius of 
the PQs, in the range of 300, 400 and 500 !m for 50,000, 100,000, and 200,000 
particles, respectively.  This indicated that a value of 100,000 to 200,000 released 
viruses per lysed cell fits best with the experimental data (compare Fig. 8B and E).  
This conclusion was further supported by the notion that the growth of simulated 
PQ was similar to the growth of experimental PQs (Fig. 8F).  We concluded that 
the RDF-based intensity profile is a sensitive tool to quantify the effective radius of 
PQs.  Moreover, the number of released particles per lysed cell has an important 
impact on the spread of HAdVs, and approximately the number of about 100,000 
particles released from infected cells match well with the experimental dynamics of 
our system.  
 
 
Discussion  
The mode of virus transmission contributes to disease progression and 
pathogenesis, but it is not easy to determine if a virus is transmitted in cell-free or 
cell-associated manner, since both modes can involve extracellular viruses.  In this 
study we used plaque assays for a computational model describing adenovirus 
spread between cells.  Plaque assays are a classical method to determine viral 
titers (27).  The processes occurring during plaque formation or virus spreading 
are complex, and variable between different viruses.  For example, the spread of 
enveloped viruses may occur as a result of mixed processes of cell-free and cell-
to-cell transmissions (83).  Our work here shows that diffusion has a key role in 
cell-free transmission of species C HAdV-2.  Employing TIRF microscopy and 
virus tracking we directly measured the diffusion constant of HAdV.  By 
incorporating this measurement in a model for cell-free virus transmission, we 
show that an invariable diffusion constant of HAdV is sufficient to largely describe 
the spreading of virus in the course of plaque formation in monolayers.  
Our study shows that HAdV-2/5 spreads from infected to non-infected cells in a 
monolayer predominantly by the cell-free mode.  We base this conclusion on 
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several lines of experimental evidence.  First, HAdV spread occurred only if the 
infected donor cell underwent lysis.  Second, viral spreading was strongly affected 
by convection.  We show by time-lapse epi-fluorescent microscopy that convection 
is largely attenuated on cells overlaid with semi-solid agarose medium.  
Significantly, the plaques in tilted plates formed underneath semi-solid medium 
had a round appearance.  Third, extracellular antibodies largely neutralized 
adenovirus spreading.   
From these findings, we established a computational model for the propagation of 
HAdV infection in cultured cells.  It is a hybrid, discrete and spatio-temporal model 
with two random components, the time from cell infection to lysis, and the number 
of progeny viruses released upon lysis.  A uniform distribution for the former is 
justified, since the mechanism of lysis is not known, and for the latter we found a 
value of 100,000 viruses per cell to best fit the experimental data.  Our multi-scale 
model combines a CA and a partial differential equation, which was discretized to 
describe the diffusion of viruses in the cell-free environment using the PSE (25). 
PSE is a powerful method, as shown previously for simulations of biological 
diffusion processes (85, 87).  To our knowledge, the model presented here is the 
first CA-PSE hybrid model.  The model demonstrates good predictive abilities for 
both qualitative and quantitative phenotypic features of viral spreading, although it 
does not take into account the movements of cells, and involves simple hexagonal 
grid geometry (76).  The model quantitatively describes that HAdV spreads by 
diffusion, and under some conditions advection components.   
We anticipate that passive mass transfer processes control the progression of 
infection in confined environments, particularly prone to bulk motions, such as the 
extracellular fluid in epithelial tissues.  As shown here, bulk motions affect the local 
concentrations of virus particles around uninfected cells, and influence the 
probability of infection, as documented by hyper-infection.  This suggests that high 
multiplicity infections may have pathological relevance.  Additionally, cell-free viral 
transmissions drive lytic infections with large burst sizes enabling infections of 
neighboring cells by avidity binding to low affinity receptors, for example, binding 
of oncolytic species B1 HAdV to CD46 (105).  Large burst sizes can also 
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compensate for genetic deficiencies of individual particles by trans-
complementation.  
The modelling platform established here provides a basis for analysing cell-free 
aspects of both lytic and non-lytic viral transmissions.  Cell-free lytic transmissions 
widely occur for both enveloped and non-enveloped viruses.  Examples for the 
former are poxviruses or measles virus, and the latter picornaviruses, reoviruses 
or adenoviruses (3, 95).  Cell-free transmissions neither require particular cell-cell 
contact sites, nor the down-regulation of viral receptors from infected cells to 
detach viruses from the producer cell.  Cell-free transmissions are also a major 
pathway for viral spread between individuals through body fluids or organ 
transplantations.  This is also important for viruses, which use intra-organismic 
cell-cell transmission routes, such as HIV, HCV or herpes viruses (reviewed in 72, 
83).  In addition, viral spreading by cell lysis is crucial for the therapeutic efficacy of 
oncolytic viruses, including HAdV (5, 80, 84).   
We expect that our model will be useful to analyse cell-free virus transmissions in 
different disease processes, where it is difficult to experimentally determine the 
specific impact of cell-free or cell-cell transmission modes.  For this, the diffusive 
properties of most current known viruses can be accurately predicted using the 
Einstein-Stokes equation, and the CA component of the hybrid model can be 
readily extended to include proximity effects, which will allow the modelling of cell-
cell spreading.   
Our model for the passive mass transfer of cell free viruses can potentially be 
combined with models for cell-to-cell spread, such as a stochastic model 
described for Sendaivirus spread (21).  Combining discrete and random modeling 
in lytic and non-lytic transmissions can be interesting for enveloped viruses.  For 
example, extracellular enveloped vaccinia viruses use a cell-cell transmission 
mode to enhance spreading beyond the speed of a single replication cycle (26, 
88), whereas intracellular viruses and inclusion particles of aggregated viruses are 
released upon cell lysis (95).  Likewise, the impact of cell-free transmission on 
human cytomegalovirus (HCMV) or hepatitis virus C (HCV) infections are 
unknown.  It is remarkable, however, that HCMV from endothelial cells is 
transmitted between endothelial cells by cell-cell contacts and avoids the cell-free 
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route, whereas HCMV from fibroblasts chooses a cell-free route to infect 
fibroblasts or endothelial cells (90).  Extracellular HCMVs are prevalent, since 
hyper-immune globulins against HCMV exhibit strong neutralization effects in 
decidual organ cultures (110).  Similarly, antibodies against the hyper-variable 
region 1 or the CD81 binding site of the HCV E2 glycoprotein have virus-
neutralizing effects in co-cultures of producer and acceptor cells, although these 
effects vary between genotypes suggesting that also virus specific factors 
contribute the transmission mode (13).  For HCMV, it has been shown that the 
transmission depends on the protein composition of the viruses (90).  In addition, 
the physiology of the tissue plays a major role for the transmission mode.  The 
tight cell-cell contacts in the liver, for example, may favor cell-cell transmission 
routes of HCV (62), whereas tissues with looser cell-cell contacts may enable viral 
spread by diffusion (41, 94).   
For therapeutic purposes, this opens the possibility of experimentally degrading 
parts of the extracellular matrix or triggering apoptosis in tumour tissues in order to 
enhance viral spreading within the tumour by diffusive processes (94).  
Furthermore, inflammatory conditions with rapidly changing compositions of the 
extracellular matrix, for example in periodontitis (93), may enhance viral 
susceptibility by diffusive spreading processes.  Our work here lays a foundation 
for the elucidation of viral cell transmission mechanisms that are determined by 
parameters, which are difficult to measure in tissues, such as diffusive properties 
of viruses in extracellular matrix of connective tissue, airway mucus, intestines or 
cervico-vaginal tracts (42, 53, 67).  
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Figures legends 
Fig. 1: The formation of plaques around infected lysed cells 
A transgenic, replication-competent Ad2 with the dE3B region substituted by a 
CMV-GFP cassette (Ad2-dE3B-GFP) was used to infect monolayers of human 
lung carcinoma A549 (HLC-A549) cells at 5•10-7 mg/ml in 200 !l of culture 
medium.  Infection progression was imaged by multi-site time-lapse fluorescence 
microscopy.  Panel (A) shows the GFP signals from infected cells at indicated time 
points of infection.  Note the occurrence of circular zones of GFP-positive cells 
around an initially infected cell, a so-called plaque.  The arrows in the figure points 
to the lysing infected cell.  Panel (B) is an overlay of the GFP signal from infected 
cells (green), Hoechst 33342 nuclear live dye (Hoechst, blue), and propidium 
iodide for lysed cells (PI, red).  See also Fig. S1 and Movie S1.  
 
Fig. 2: Cell-to-cell of infection occurs through the extracellular medium  
(A, B) Monolayers of HLC-A549 were inoculated with Ad2-dE3B-GFP expressing 
eGFP.  2h later, the inoculum was substituted with liquid or gel-forming (semi-
solid) medium (0.6% of ultra low melting agarose mass).  This agarose is liquid at 
37°C, gels at room temperature, and remains gelled at 37°C.  PQs exhibit comet-
like shapes in liquid medium and circular shapes in semi-solid medium.  The 
micrographs are composites of stitched images taken from multiple sites in 96-well 
plates at 113.5 hpi.  (C) Neutralizing antiserum against HAdV in the culture 
medium inhibits viral spreading.  HLC-A549 cells grown in monolayers in 96-well 
plates were inoculated with 0.1 ml of medium containing 10-7 mg/ml Ad2-dE3B-
GFP for 24 h, supplemented with antiserum containing medium, and then imaged 
at indicated time points.  Scale bar = 1 mm.  See also Fig. S2 and Fig. S3, and 
Movie S2, Movie S3. 
 
Fig. 3: Replication-defective HAdV spreads to neighboring cells from an 
infected donor cell 
Ad2-dE1-GFP infected HER-911 donor cells were seeded at limiting dilutions onto 
HLC-A549 acceptor cells (1 in 800), which can be infected but do not produce 
virus particles.  The figure shows PQs of Ad2-dE1-GFP, Hoechst and propidium 
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iodide (PI) composites of a single round of infection.  The arrows point to a lysing 
HER-911 cell.  See also Fig. S4 and Fig. S5.  
 
Fig. 4: A hybrid model consisting of a cellular automaton (CA) - particle 
strength exchange (PSE) 
(A) Flow chart of the CA-PSE model, and (B) cell state flow chart. Nviruses is the 
number of diffusing, cell-free viral particles, p has a random value from a uniform 
distribution U(0,1), P(Nviruses | Infected) is the probability of infection upon exposure 
to Nviruses virus particles, dt is the CA time step, P(lysis) is the probability of cell 
lysis, PT(death) is the time-dependent probability for an uninfected cell to die, and 
Tlysis is the time until cell lysis. 
 
Fig. 5: Parameters of the hybrid cellular automaton - particle strength 
exchange (CA-PSE) model 
The parameters listed on the left hand side affect the CA while parameters listed 
on the right hand side affect the PSE.  Parameter values were all derived from 
experiments in this study except the number of viral particles produced from a lytic 
infected cell.  This latter value was adopted from (40). 
 
Fig. 6: Infection probability, GFP expression kinetics and overall cell death 
are viral dose-dependent  
(A) Multi-site time-lapse imaging of HLC-A549 cells infected with different 
amounts.  Automated computational cell segmentation using CellProfiler was used 
to count all cells and determine the fraction of infected cells.  This allowed 
measuring the infection probability as a function of input virus protein 
concentration.  Measurements were performed 72 hpi. 
(B) To convert the virus protein concentration to the number of viral particles, we 
used a theoretical number of HAdV particles (TNAP).  It was determined from the 
protein mass of an individual adenovirus particle as described in equation (1).  The 
mean GFP intensity (averaged per well) was measured for each virus 
concentration.  Measurements were made per concentration and per time point 
with a time resolution of 1 h.  This allowed calibrating the GFP intensity increase 
as a function of time and input Ad2-dE3B-GFP.  See also Movie S4 and Fig. S7. 
 39 
(C) Cells were imaged in the presence of propidium iodide dye (PI) and Hoechst 
33342 dye (Hoechst) over 120.5 h.  The number of PI-positive cells was plotted for 
infected (blue) and non-infected (red) cells.  Quantification was by CellProfiler 
based on the Hoechst and PI signals. 
 
Fig. 7: Simulation output from the hybrid cellular automaton - particle 
strength exchange 
An example of a simulation for AdV2-dE3B-GFP infection is shown.  The figure 
shows the hexagonal CA cell mesh outlined in blue with color-coded cells: red – 
dead, green – infected.  The green color intensities represent relative GFP levels.  
See also Supplementary Movie S5.   
 
Fig. 8: Model validation by radial distribution function of PQ reveals how 
local HAdV concentrations affect infection 
(A) The micrograph and the fluorescence intensity profile depicted in the line 
graph represent a PQ from a single round HLC-A549 infection with Ad2-dE1-GFP, 
analyzed by the radial distribution function (RDF).  The RDF provides a distance-
dependent sampling of the mean fluorescence intensity averaged around 
concentric rings around the PQ center.  The radius (r) of a PQ is defined as the 
distance between the PQ center and the radial position where the fluorescence 
intensity drops to the level of background intensity, which was estimated from cells 
in uninfected control wells.  Panels B-C show average RDFs from 15 different 
experimental PQs with Ad2-dE3B-GFP (B) or simulated PQs (C) 113 hpi (solid 
line), including the +/- one sigma band (dashed lines), and the background 
fluorescence from the experimental images (dotted line).  Fluorescence values 
were obtained using linear interpolation in the experimental calibration curve.  In 
(C), the number of released progeny virus particles was assumed to be 100,000 
per lytic infected cell.  Hyper-infection of cells close to the lytic infected cell in the 
PQ center was allowed in the simulation.  Panel (D) depicts the average simulated 
RDF without hyper-infection 113 hpi.  Panel (E) shows the average simulated 
mean RDFs for different numbers of released progeny viruses per lysed cell 113 
hpi, 50,000 particles (green), 100,000 particles (blue), 200,000 particles (red) 
allowing for hyper-infection.  Panel (F) shows three representative examples for 
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time resolved PQ formation from Ad2-dE3B-GFP infected HLC-A549 cells (colored 
lines), and a simulated PQ using 100,000 released particles per cell and allowing 
for hyper-infection (dashed grey line).  The observation period was from 43 to 113 
hpi.   
 
 
!
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Table 1: Reynolds numbers (Re) for beads with variable size 
bead 
diameter (m) 
maximal Re from 
instantaneous 
speed* 
maximal Re 
from mean 
speed* 
Re from theoretical 
instantaneous speed* 
!"#$%&'('$ - - )"'&%&'() 
&"&*%&'('+ &"+)%&'(* !"$)%&'(, &"&#%&'() 
)"'#%&'('+ ,")'%&'(* +")#%&'(, $"++%&'(! 
,"&-%&'('+ &"!#%&'(! !"'-%&'(* ,",$%&'(! 
+"*$%&'('+ &")#%&'(! )"*-%&'(* *"-!%&'(! 
&"')%&'('- )",-%&'(! *"-$%&'(* !"#+%&'(! 
* Material, methods and models for detailed description of calculation methods 
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Table 2: Phenotypic parameters of biological and in silico plaques (PQ) 
 mean radius, (!m)* 
infected 
cells 
(number)* 
total cells 
(number)* 
speed of spreading 
front (!m/h)* 
biological 
PQs 471±58 629±262 1776±418 4±1 
in silico PQs 513±55 347±21 1591±334 5.8±0.6 
 
* Materials, methods and models provide details on the calculation methods 
!
!
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Supplemental figures, movies and legends 
Fig. S1 
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Fig. S1: Ad2-dE3B-GFP and Ad2 give rise to similar plaques on HLC-A549 cells 
Cells grown in monolayers on 12-well plates were inoculated with virus at 37°C for 1 
h, inoculum was removed and cells covered with agar overlay in growth medium as 
described earlier [1].  Four to eight days post infection (dpi), cells were fixed and 
stained with crystal violet.  Panel A shows scans of stained plates and uninfected 
control cells.  Panel B shows a plot of average plaque diameters including standard 
deviations as a function of infection time using ImageJ software for fitting circles of 
respective diameters to the plaques identified in the crystal violet stained cells.  
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Fig. S2: Advection and diffusion control the shape of Ad2-dE3B-GFP plaques in 
liquid medium 
HLC-A549 cells were inoculated with Ad2-dE3B-GFP in growth medium at 37°C for 2 
h, washed in medium, and overlaid with liquid medium or medium containing 0.6% 
agarose (gelled medium).  Plates were either tilted by 37° derived from arctan of the 
stand height and the plate width (measured with mm precision), or left horizontal and 
imaged for GFP analyses 5 dpi without fixation as described in Materials and 
Methods.  Panel A shows an overview of a tilted plate, and B and C show close ups 
of tilted or horizontal plates.  GFP intensities are indicated as arbitrary linear intensity 
units (a.i.u.) in pseudo-colours on the left.  The Hoechst 33342 signal indicating cell 
nuclei is not shown here.  
Note that that there is no preferred directionality of the plaque comets in the 
horizontal plate, while the comets in the tilted plate are largely aligned ‘uphill’ 
presumably under the influence of advection.  The cells overlaid with agarose did not 
show comet plaques, neither tilted nor horizontal.  We conclude that comet plaques 
are results of convection composed of advection and diffusion, while the symmetrical 
plaques under agarose are the result of diffusion.  
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Fig. S3 
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Fig. S3: Anti-HAdV-2/5 antiserum blocks infection and virus spreading 
Ad2-dE3B-GFP or control medium was added to HLC-A549 cells in 384 well 
monolayers at 37°C for 1 h in presence or absence of native or heat-inactivated anti-
adenovirus antiserum (AS).  Cells were imaged in the GFP and the Hoechst 33342 
channels 20 hpi (panel A), and the fraction of infected cells quantified using 
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CellProfiler (v2.0) based on Hoechst (cell nuclei) and GFP infection signals.  The 
results show dose-dependent virus neutralization by the AS.  Panel C shows GFP 
signals of infected cells in plate overviews 5 dpi, in presence or absence of different 
concentrations of AS.  These data demonstrate blocking effects by the neutralizing 
AS on plaque formation.  Panels D and E show end point titration assays with 
multiple rounds of infection, confirming the neutralization efficacy of AS.  Various 
amounts of Ad5 were incubated with different dilutions of neutralizing AS (D), or non-
neutralizing boiled AS (E) in 50 !l of medium in 96 well plates at room temperature 
for 15 to 30 min, followed by addition of HLC-A549 cells.  The cells were fixed, and 
stained with crystal violet (dark color) 7 dpi.  Wells where cells were detached or 
lysed by the virus appear transparent.  
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Fig. S4: Co-culture of infected HER-911 and uninfected HLC-A549 cells reveals 
virus spreading in single round infections 
HER-911 cells were infected with Ad2-dE1-GFP, stained with CellMask red live dye, 
detached and seeded onto uninfected HLC-A549 cells.  Cells were fixed 22 h post 
seeding and stained with the DNA-dye Hoechst.  (A) Imaging of GFP (infection) and 
CellMask red live dye (HER-911) indicates that the donor HER-911 cells are positive 
for GFP.  Panel (B) shows a plot of the number of CellMask positive cells and the 
number of GFP-positive cells, indicating a strong correlation between the two signals.  
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Fig. S5: Semi-solid agarose medium restricts advection of Ad2-dE1-GFP in 
absence of second round of infection 
(A) Lysis of a HER-911 donor cell among uninfected HLC-A549 cells.  Color 
composites show GFP (green), Hoechst 33342 (blue) and propidium iodide (red).  
Roughly spherical plaques seen in HLC-A549 cells under semi-solid 0.6 % agarose 
medium (B), and elongated plaques in aqueous medium (C).  Multiple images (6x6) 
were stitched to give an overview impression.  Each square image represents an 
imaging site from a single well taken in a time-lapse automated fluorescence 
microscopy experiment.  Bar = 1 mm.  Time points in the upper left corners are 
designated in hpi. 
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Fig. S6: Measurement of diffusion constants from fluorescent beads 
Graphical representation of the diffusion constants for different sized fluorescent 
polymer beads in distilled water (A) or imaging medium (B).  Diffusion constants of 
various sized fluorescent beads were measured experimentally, or calculated using 
Einstein-Stokes relation (equation 2 in the main text).  (C) Diffusion constants of Ad2-
atto565 were experimentally measured in imaging medium containing different 
concentrations of agarose yielding semi-solid medium.  Error bars represent standard 
deviations of the mean diffusion constants of fluorescent beads obtained using 
moment scaling spectrum slopes [2] of Brownian motion trajectories tracked in 50 
independent measurements (movies) for each condition. 
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 Figure S7 
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Fig. S7: Infection probability and GFP expression kinetics depend on the dose 
of Ad2-dE1-GFP 
Multi-site time-lapse imaging of HLC-A549 cells infected with different amounts of 
Ad2-dE1-GFP was performed, and analyzed for infection probability depending on 
the dose of input virus.  CellProfiler software was used to classify infected and 
uninfected cells.  (A) The fractions of infected cells depend on amounts of virus input 
shown as virus protein concentration and theoretical number of adenovirus particles.  
(B) GFP intensities averaged per well as a measure of infection are plotted for each 
virus concentration (mg protein per ml) at the time points indicated by the color scale 
on the right side of the panel.   
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Movie_S1 
 
 
 
Movie S1: The formation of plaques occurs after cell lysis 
Human lung carcinoma A549 (HLC-A549) cells were cultivated in monolayers, 
inoculated with highly diluted purified Ad2-dE3B-GFP (10-7 mg virus protein in 200 !l 
cell culture medium) and imaged for GFP expression by multi-site time-lapse 
fluorescence microscopy.  The sporadic occurrence of a small fraction of GFP-
positive cells was observed before 44.5 hpi.  Note that GFP behaves as a soluble 
protein and freely equilibrates in the cytosol and the nucleus [3].  At 2-3 dpi, circular 
zones of GFP-positive infected cells developed around some of the initially infected 
cells. An infected cell (GFP positive, green) became positive for propidium iodide dye 
(PI) after disappearance of the GFP signal, which indicated cell lysis.  This is followed 
by the formation of an SP.   
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 Movie_S2 
 
 
 
Movie S2: Semi-solid medium restricts advection and leads to the formation of 
circular plaques 
Time-lapse microscopy revealed the influence of a semi-solid medium gelled 0.6% 
agarose (movie on the left side) on the shape of plaques, compared to the liquid 
medium (movie on the right side).  Multiple sites and multiple wells were stitched 
together to yield overview movies. 
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Movie_S3 
 
 
 
Movie S3: Neutralizing anti-Ad2/5 antiserum blocks the formation of plaques by 
Ad2-dE3B-GFP 
Time-lapse microscopy revealed a dose-dependent spreading arrest by a 
neutralizing anti-Ad2/5 antiserum.  The initial infection occurred with 10-6 mg/ml of 
Ad2-dE3B-GFP.  Low-resolution overview images of stitched multiple sites and 
multiple wells are shown.  The montages reveal the arrest in formation of plaques 
recognized as GFP expressing cells (gray scale signals). 
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Movie_S4 
 
 
 
 
Movie S4: GFP expression kinetics depends on the dose of input Ad2-dE3B-
GFP 
Multi-site time-lapse imaging of HLC-A549 cells infected with different amounts of 
Ad2-dE3B-GFP virus shows decreasing levels of infection as the amounts of input 
virus decrease from left to right and from the upper to the lower row of triplicate 
samples.  Each square image represents an imaging site from a well containing 200 
!l of samples.  Triplicates represent different wells infected with the same amounts of 
virus.  The first three control wells were not infected. 
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Movie_S5 
 
 
 
Movie S5: Simulation output from the hybrid model encompassing cellular 
automaton - particle strength exchange (CA-PSE)  
The cells for the hexagon-based CA are outlined in blue and dead cells in red.  
Infected cells are denoted in green, where high green intensities reflect high levels of 
infection, and low intensities low infections.  The animation starts 1 hpi, and has a 
temporal resolution of 1 h per frame. 
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